N@N

Astro-Med, Inc. to Present at Needham & Company 12th Annual Growth Conference

_{//science-technology.news-articles.net/content/2 .. edham-company-12th-annual-growth-conference.html}
^{Published in Science and Technology on Wednesday, January 6th 2010 at 12:50 GMT by Market Wire}  

WEST WARWICK, RI--(Marketwire - January 6, 2010) - Astro-Med, Inc. (NASDAQ: [ ALOT ]) today announced that it will present at the Needham & Company, LLC 12th Annual Growth Conference in New York City on Thursday, January 14, 2010 at 8:00 am. Albert W. Ondis, Chairman and CEO, will give a presentation detailing the company's strategy for growth and profitability.

A live audio web cast of the presentation will be available on the Astro-Med, Inc. corporate web site at [ www.Astro-MedInc.com ]. Following the presentation, Ondis and Joseph P. O'Connell, Senior Vice President and CFO, will engage in a series of one-on-one sessions with institutional investors throughout the day.

This is the 8th year Astro-Med, Inc. has been invited to present to the Needham & Company Growth Conference. Organized annually, the Conference has become one of the largest growth conferences on Wall Street. 1500 institutional investors and venture capital professionals are expected to attend from January 12 - 14, 2010 to hear presentations from 300 growth companies.

About Astro-Med, Inc.

Astro-Med, Inc. is a leading manufacturer of specialty high tech specialty printing systems, electronic medical instrumentation, and test and measurement instruments. Astro-Med, Inc. products are sold under the brand names Astro-Med®, Grass® Technologies and QuickLabel® Systems, and are employed around the world in a wide range of aerospace, medical, military, industrial, and packaging applications. Astro-Med, Inc. is a member of the Russell Microcap® Index. Additional information is available by visiting [ www.Astro-MedInc.com ].

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2009 Annual Report and its annual and quarterly filings with the Securities and Exchange Commission.